{
    "2019-09-27": [
        [
            {
                "time": "2023-03-15",
                "original_text": "IntelGenx (IGXT) Resubmits NDA for Migraine Candidate to FDA",
                "features": {
                    "keywords": [
                        "IntelGenx",
                        "NDA",
                        "Migraine",
                        "FDA"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Incyte (INCY) Stock Up 16% YTD on Strong Jakafi Performance",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Stock",
                        "Jakafi",
                        "Performance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}